The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
RAN Translation in Huntington Disease
Open accessAbstract
SUMMARY Huntington disease (HD) is caused by a CAG·CTG expansion in the huntingtin (HTT) gene. While most research has focused on the HTT polyGln-expansion protein, we demonstrate that four additional, novel, homopolymeric expansion proteins (polyAla, polySer, polyLeu, and polyCys) accumulate in HD human brains. These sense and antisense repeat-associated non-ATG (RAN) translation proteins accumulate most abundantly in brain regions with neuronal loss, microglial activation and apoptosis, including caudate/putamen, white matter, and, in juvenile-onset cases, also the cerebellum. RAN protein accumulation and aggregation are length dependent, and individual RAN proteins are toxic to neural cells independent of RNA effects. These data suggest RAN proteins contribute to HD and that therapeutic strategies targeting both sense and antisense genes may be required for efficacy in HD patients. This is the first demonstration that RAN proteins are expressed across an expansion located in an open reading frame and suggests RAN translation may also contribute to other poly-glutamine diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trinucleotide Repeat Disorders
Orr, H. T., & Zoghbi, H. Y. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113042 · Cited by 1,368
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Mori, K., Weng, S.-M., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Van Broeckhoven, C., et al. (2013) · Science · doi:10.1126/science.1232927 · Cited by 1,277
Ash, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T., Lin, W.-L., DeJesus-Hernandez, M., van Blitterswijk, M. M., Jansen-West, K., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,100
Non-ATG–initiated translation directed by microsatellite expansions
Zu, T., Gibbens, B., Doty, N. S., Gomes-Pereira, M., Huguet, A., Stone, M. D., Margolis, J., Peterson, M., Markowski, T. W., Ingram, M. A. C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013343108 · Cited by 903
Self-citationKordasiewicz, H. B., Stanek, L. M., Wancewicz, E. V., Mazur, C., McAlonis, M. M., Pytel, K. A., Artates, J. W., Weiss, A., Cheng, S. H., Shihabuddin, L. S., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.05.009 · Cited by 770
RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia
Zu, T., Liu, Y., Bañez-Coronel, M., Reid, T., Pletnikova, O., Lewis, J., Miller, T. M., Harms, M. B., Falchook, A. E., Subramony, S. H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315438110 · Cited by 760
Self-citationSchilling, G. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.3.397 · Cited by 753
Björkqvist, M., Wild, E. J., Thiele, J., Silvestroni, A., Andre, R., Lahiri, N., Raibon, E., Lee, R. V., Benn, C. L., Soulet, D., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080178 · Cited by 650
Gray, M., Shirasaki, D. I., Cepeda, C., Andre, V. M., Wilburn, B., Lu, X.-H., Tao, J., Yamazaki, I., Li, S.-H., Sun, Y. E., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0857-08.2008 · Cited by 613
CGG Repeat-Associated Translation Mediates Neurodegeneration in Fragile X Tremor Ataxia Syndrome
Todd, P. K., Oh, S. Y., Krans, A., He, F., Sellier, C., Frazer, M., Renoux, A. J., Chen, K.-C., Scaglione, K. M., Basrur, V., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.03.026 · Cited by 478
Microglial activation correlates with severity in Huntington disease: A clinical and PET study
Pavese, N., Gerhard, A., Tai, Y. F., Ho, A. K., Turkheimer, F., Barker, R. A., Brooks, D. J., & Piccini, P. (2006) · Neurology · doi:10.1212/01.wnl.0000222734.56412.17 · Cited by 462 · cited 2×
“Taken together, these results raise the possibility that HD-RAN proteins trigger neuroinflammatory changes (Björkqvist et al., 2008, 2009; Myers et al., 1991; Pavese et al., 2006; Tai et al., 2007) and cell death in HD.”
Rosas, H. D., Tuch, D. S., Hevelone, N. D., Zaleta, A. K., Vangel, M., Hersch, S. M., & Salat, D. H. (2006) · Movement Disorders · doi:10.1002/mds.20979 · Cited by 346
Bates, G. P., Murphy, K., Harper, P. S., & Jones, L. A. (2002) · Cited by 263
Decreased Neuronal and Increased Oligodendroglial Densities in Huntington's Disease Caudate Nucleus
Myers, R. H., Vonsattel, J. P., Paskevich, P. A., Kiely, D. K., Stevens, T. J., Cupples, L. A., Richardson, E. P., & Bird, E. D. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00005 · Cited by 239
Striatal and white matter predictors of estimated diagnosis for Huntington disease
Paulsen, J. S., Nopoulos, P. C., Aylward, E., Ross, C. A., Johnson, H., Magnotta, V. A., Juhl, A., Pierson, R. K., Mills, J., Langbehn, D., et al. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.003 · Cited by 223
Self-citationA natural antisense transcript at the Huntington's disease repeat locus regulates HTT expression
Chung, D. W., Rudnicki, D. D., Yu, L., & Margolis, R. L. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr263 · Cited by 194
Self-citationBañez-Coronel, M., Porta, S., Kagerbauer, B., Mateu-Huertas, E., Pantano, L., Ferrer, I., Guzmán, M., Estivill, X., & Martí, E. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002481 · Cited by 188
Self-citationIn vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease
Fennema-Notestine, C., Archibald, S. L., Jacobson, M. W., Corey-Bloom, J., Paulsen, J. S., Peavy, G. M., Gamst, A. C., Hamilton, J. M., Salmon, D. P., & Jernigan, T. L. (2004) · Neurology · doi:10.1212/01.wnl.0000138434.68093.67 · Cited by 166
The gait abnormality of Huntington's disease
Koller, W. C., & Trimble, J. (1985) · Neurology · doi:10.1212/wnl.35.10.1450 · Cited by 161
Imaging microglial activation in Huntington's disease
Tai, Y., Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A., Brooks, D. J., & Piccini, P. P. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.10.029 · Cited by 155
Reading, S. A. J., Yassa, M. A., Bakker, A., Dziorny, A. C., Gourley, L. M., Yallapragada, V., Rosenblatt, A., Margolis, R. L., Aylward, E., Brandt, J., et al. (2005) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2005.05.011 · Cited by 151
Self-citationRüb, U., Hoche, F., Brunt, E. R. P., Heinsen, H., Seidel, K., Turco, D. D., Paulson, H. L., Böhl, J., von Gall, C., Vonsattel, J., et al. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00629.x · Cited by 150
Diagnosis of Huntington Disease
Margolis, R. L., & Ross, C. A. (2003) · Clinical Chemistry · doi:10.1373/49.10.1726 · Cited by 120
Self-citationRepeat associated non-ATG (RAN) translation: new starts in microsatellite expansion disorders
Cleary, J. D., & Ranum, L. P. W. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.03.002 · Cited by 114
Self-citationAnalysis of a very large trinucleotide repeat in a patient with juvenile Huntington’s disease
NANCE, M. A., Mathias-Hagen, V., Breningstall, G. N., Wick, M. J., & McGlennen, R. C. (1999) · Neurology · doi:10.1212/wnl.52.2.392 · Cited by 113
Bohanna, I., Georgiou‐Karistianis, N., Sritharan, A., Asadi, H., Johnston, L. A., Churchyard, A., & Egan, G. F. (2011) · Brain Imaging and Behavior · doi:10.1007/s11682-011-9121-8 · Cited by 97
Ross, C. A., Wood, J. D., Schilling, G., Peters, M. F., Nucifora, F. C., Cooper, J. K., Sharp, A. H., Margolis, R. L., & Borchelt, D. (1999) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1999.0452 · Cited by 93
Self-citationAnimal models of Huntington's disease for translation to the clinic: Best practices
Menalled, L., & Brunner, D. (2014) · Movement Disorders · doi:10.1002/mds.26006 · Cited by 85
CAG tract of MJD-1 may be prone to frameshifts causing polyalanine accumulation
Gaspar, C. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.13.1957 · Cited by 65
Ribosomal frameshifting on MJD-1 transcripts with long CAG tracts
Toulouse, A., Au-Yeung, F., Gaspar, C., Roussel, J., Dion, P. A., & Rouleau, G. A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi299 · Cited by 62
Lee, C. Y. D., Cantle, J. P., & Yang, X. W. (2013) · FEBS Journal · doi:10.1111/febs.12418 · Cited by 58
Neuroanatomic Profile of Polyglutamine Immunoreactivity in Huntington Disease Brains
Herndon, E. S., Hladik, C. L., Shang, P., Burns, D. K., Raisanen, J., & White, C. L. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318198d320 · Cited by 57
Early onset Huntington disease: a neuronal degeneration syndrome
Seneca, S., Fagnart, D., Keymolen, K., Lissens, W., Hasaerts, D., Debulpaep, S., Desprechins, B., Liebaers, I., & Meırleır, L. D. (2004) · European Journal of Pediatrics · doi:10.1007/s00431-004-1537-3 · Cited by 55
Expanded ATXN3 frameshifting events are toxic in Drosophila and mammalian neuron models
Stochmanski, S. J., Therrien, M., Laganière, J., Rochefort, D. L., Laurent, S. B., Karemera, L., Gaudet, R., Vyboh, K., van Meyel, D. J., Cristo, G. D., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds036 · Cited by 49
Harnessing Immune Alterations in Neurodegenerative Diseases
Björkqvist, M., Wild, E. J., & Tabrizi, S. J. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.034 · Cited by 40
Mouse Models of Polyglutamine Diseases in Therapeutic Approaches: Review and Data Table. Part II
Switonski, P. M., Szlachcic, W. J., Gabka, A., Krzyżosiak, W. J., & Figiel, M. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8316-3 · Cited by 40
Hu, J., Liu, J., Yu, D., Chu, Y., & Corey, D. R. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks907 · Cited by 40
O’Brien, R., DeGiacomo, F., Holcomb, J., Bonner, A., Ring, K. L., Zhang, N., Zafar, K. S., Weiss, A., Lager, B., Schilling, B., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.623561 · Cited by 22
Cited by
Huntington's disease: a clinical review
McColgan, P., & Tabrizi, S. J. (2018) · European Journal of Neurology · doi:10.1111/ene.13413 · Cited by 1,089
Liquid–Liquid Phase Separation in Disease
Alberti, S., & Dormann, D. (2019) · Annual Review of Genetics · doi:10.1146/annurev-genet-112618-043527 · Cited by 868
Klockgether, T., Mariotti, C., & Paulson, H. L. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0074-3 · Cited by 696
Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
Tabrizi, S. J., Flower, M. D., Ross, C. A., & Wild, E. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0389-4 · Cited by 538
Self-citation30 years of repeat expansion disorders: What have we learned and what are the remaining challenges?
Depienne, C., & Mandel, J.-L. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.03.011 · Cited by 429
Metadata
- Authors
- Bañez-Coronel, M., Ayhan, F., Tarabochia, A. D., Zu, T., Perez, B. A., Tusi, S. K., Pletnikova, O., Borchelt, D. R., Ross, C. A., Margolis, R. L., Yachnis, A. T., Troncoso, J. C., & Ranum, L. P. W.
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 88
- Issue
- 4
- Pages
- 667-677
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2181090621
- Cited by
- 354
- References
- 38
- FWCI
- 13.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.